ATE40946T1 - Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. - Google Patents

Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.

Info

Publication number
ATE40946T1
ATE40946T1 AT84102485T AT84102485T ATE40946T1 AT E40946 T1 ATE40946 T1 AT E40946T1 AT 84102485 T AT84102485 T AT 84102485T AT 84102485 T AT84102485 T AT 84102485T AT E40946 T1 ATE40946 T1 AT E40946T1
Authority
AT
Austria
Prior art keywords
prophylactic agent
epilepsy
medicinal
treatment
remedial
Prior art date
Application number
AT84102485T
Other languages
English (en)
Inventor
Norio Ogawa
Shuji Tsukamoto
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE40946T1 publication Critical patent/ATE40946T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
AT84102485T 1983-03-08 1984-03-08 Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. ATE40946T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58036568A JPS59163316A (ja) 1983-03-08 1983-03-08 けいれんの治療・予防剤
EP84102485A EP0118132B1 (de) 1983-03-08 1984-03-08 Arzneimittel oder prophylaktisches Mittel zur Behandlung von Epilepsie

Publications (1)

Publication Number Publication Date
ATE40946T1 true ATE40946T1 (de) 1989-03-15

Family

ID=12473362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84102485T ATE40946T1 (de) 1983-03-08 1984-03-08 Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.

Country Status (5)

Country Link
US (1) US4491594A (de)
EP (1) EP0118132B1 (de)
JP (1) JPS59163316A (de)
AT (1) ATE40946T1 (de)
DE (1) DE3476847D1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4885167A (en) * 1985-04-19 1989-12-05 Board Of Regents, The University Of Texas System Restoration of impaired cardiac function of patients with diverse muscular dystrophies by therapy with coenzyme Q10
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
US5343512A (en) * 1992-03-27 1994-08-30 Motorola, Inc. Call setup method for use with a network having mobile end users
ATE271614T1 (de) * 1992-05-28 2004-08-15 Ct For Molecular Biology And M Quinone-derivate zur verbesserung der zellulare bioenergie
CN100391447C (zh) * 2004-01-15 2008-06-04 范敏华 一种辅酶q10冻干粉针剂及其制备方法
US20060111743A1 (en) * 2004-11-19 2006-05-25 Gurney Harry C Jr Method for arresting seizure activity
CA2610152C (en) 2005-06-01 2018-04-10 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
PL1933821T3 (pl) * 2005-09-15 2021-01-11 Ptc Therapeutics, Inc. Warianty łańcucha końcowego środków terapeutycznych o aktywności redoks do leczenia chorób mitochondrialnych i innych stanów oraz do modulacji biomarkerów energetycznych
EP1986636B1 (de) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol- und 1,4-benzochinon-derivate zur verwendung in der behandlung von erkrankungen der mitochondrien
EP2344142B1 (de) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Behandlung von pervasiven entwicklungsstörungen mit redox-aktiven therapeutika
MX2018007389A (es) 2015-12-17 2018-08-15 Bioelectron Tech Corp Derivados de fluoroalquil-, fluoroalcoxi-, fenoxi-, heteroariloxi-, alcoxi- y amina-1,4-benzoquinona para tratamiento de trastornos de estres oxidativo.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534137A (en) * 1965-09-30 1970-10-13 Takeda Chemical Industries Ltd Method of systemic therapy for severe early destructive periodontal disease
US3452144A (en) * 1966-03-26 1969-06-24 Takeda Chemical Industries Ltd Method for treatment of congestive heart failure with coenzyme qn
JPS5845403B2 (ja) * 1976-02-14 1983-10-08 エーザイ株式会社 補酵素ｑを主成分とする膵機能亢進剤
JPS5942649B2 (ja) * 1976-02-14 1984-10-16 エーザイ株式会社 重症筋無力症治療剤
JPS5938202B2 (ja) * 1976-03-05 1984-09-14 エーザイ株式会社 難聴治療剤

Also Published As

Publication number Publication date
EP0118132B1 (de) 1989-03-01
EP0118132A3 (en) 1985-11-06
EP0118132A2 (de) 1984-09-12
JPS59163316A (ja) 1984-09-14
DE3476847D1 (en) 1989-04-06
US4491594A (en) 1985-01-01
JPH0133082B2 (de) 1989-07-11

Similar Documents

Publication Publication Date Title
MY100343A (en) Amide derivative and external medicament comprising same
CA1273019C (en) ENKEPHALINASE INHIBITORS
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3263057D1 (en) Hair treatment compositions
ATE226014T1 (de) Prophylaktische behandlung der allergischen kontaktdermatitis
ATE40946T1 (de) Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.
HRP920667A2 (en) Application of fultripine active substance for preventing muscle deformation
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
DE69713620D1 (de) Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES8503643A1 (es) Un procedimiento para la preparacion de compuestos de bis (carboxamida)
NZ299727A (en) Preparation of valproic acid analogues and its use for treatment of epilepsy
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
ES471809A1 (es) Procedimiento para preparar derivados de naftaleno
FR2361361A1 (fr) Nouveaux derives du cyclopentane et medicaments contenant ces substances
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
SE7702130L (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ATE157660T1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
ATE167399T1 (de) Verwendung von sulfasalazin und/oder dessen aktiven metaboliten zur herstellung eines arzneimittels zur behandlung von venöser insuffizienz und venösen ulcera
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee